Pila Pharma AB Analyst Coverage

1. Initiation Coverage
[December 17, 2021]

Please read the report here

---

2. Pila Pharma Q1’22: New Project Revealed
[April 26, 2022]

Please read the report here

---

3. Pila Pharma: Adjusting for Capital Injection
[May 03, 2022]

Please read the report here

---

4. Pila Pharma: Tox Studies Initiated
[June 30, 2022]

Please read the report here

---

5. Pila Pharma Q2’22: An Aspiring TRPV1 Platform Company
[August 26, 2022]

Please read the report here

---

6. Pila Pharma: Initial Results from the 13-week safety study
[October 12, 2022]

Please read the report here

---

7. Pila Pharma Q3’22: Funding in Focus
[October 26, 2022]

Please read the report here

---

8. Pila Pharma: Rights Issue Outcome
[November 22, 2022]

Please read the report here

1. Indledende Analyse: Pila Pharma Årsrapport 2023
[April 2, 2024]

Please read the report here

---

2. analyse – Pila Pharma Halvårsrapport 2024
[September 30, 2024]

Please read the report here

---

3. Analyse: Pila Pharma Årsregnskab 2024
[March 24, 2025]

Please read the report here

---

4. Analyse: Pila Pharma Halvårsrapport 2025
[September 23, 2025]

Please read the report here